(S (NP (DT The) (NN Gleason) (NN score)) (VP (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (JJ prognostic) (NN marker)) (PP (IN for) (NP (NN prostate) (NN cancer) (NNS patients))))) (CC but) (VP (VBZ suffers) (PP (IN from) (NP (JJ significant) (NN inter-observer) (NN variability))))) (. .))
(S (NP (PRP We)) (VP (VBD developed) (NP (DT a) (ADJP (RB fully) (VBN automated)) (NML (JJ deep) (NN learning)) (NN system)) (PP (IN to) (NP (NN grade) (NN prostate) (NNS biopsies)))) (. .))
(S (NP (DT The) (NN system)) (VP (VBD was) (VP (VBN developed) (S (VP (VBG using) (NP (CD 5834) (NNS biopsies)) (PP (IN from) (NP (CD 1243) (NNS patients))))))) (. .))
(S (NP (DT A) (JJ semi-automatic) (NN labeling) (NN technique)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB circumvent) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (JJ full) (JJ manual) (NN annotation)))) (PP (IN by) (NP (NNS pathologists)))))))) (. .))
(S (NP (DT The) (JJ developed) (NN system)) (VP (VBD achieved) (NP (DT a) (JJ high) (NN agreement)) (PP (IN with) (NP (DT the) (NN reference) (NN standard)))) (. .))
(S (PP (IN In) (NP (DT a) (JJ separate) (NN observer) (NN experiment))) (, ,) (NP (DT the) (NML (JJ deep) (NN learning)) (NN system)) (VP (VBD outperformed) (NP (QP (CD 10) (IN out) (IN of) (CD 15)) (NNS pathologists))) (. .))
(S (NP (DT The) (NN system)) (VP (VBZ has) (NP (DT the) (JJ potential) (S (VP (TO to) (VP (VB improve) (NP (NN prostate) (NN cancer) (NNS prognostics)) (PP (IN by) (S (VP (VBG acting) (PP (IN as) (NP (DT a) (ADJP (JJ first) (CC or) (JJ second)) (NN reader))))))))))) (. .))
